<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercepharma.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Generics</title>
 <link>http://www.fiercepharma.com/tags/generics</link>
 <description></description>
 <language>en</language>
<item>
 <title>Plavix copycat pops up in Europe</title>
 <link>http://www.fiercepharma.com/story/plavix-copycat-pops-up-in-europe/2008-05-09?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>Call it generic Whac-a-Mole. Sanofi-Aventis and Bristol-Myers Squibb have bludgeoned copycat Plavix in the U.S., but competition is now popping up in Europe. Swiss drugmaker Schweizerhall Holding &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/plavix-copycat-pops-up-in-europe/2008-05-09&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/plavix-copycat-pops-up-in-europe/2008-05-09#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/novartis">Novartis</category>
 <category domain="http://www.fiercepharma.com/tags/plavix">Plavix</category>
 <pubDate>Fri, 09 May 2008 06:59:58 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8997 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Pharma outsourcing continues to swell</title>
 <link>http://www.fiercepharma.com/story/pharma-outsourcing-continues-to-swell/2008-05-05?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> Outsourcing is still on roll--it&#039;s just not rolling quite as fast as it did last year. Such is the conclusion of Contract Pharma&#039;s 2008 outsourcing survey, which found that 52 percent of companies &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/pharma-outsourcing-continues-to-swell/2008-05-05&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/pharma-outsourcing-continues-to-swell/2008-05-05#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/asia">Asia</category>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/outsourcing">outsourcing</category>
 <pubDate>Mon, 05 May 2008 06:59:57 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8949 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Could Clarinex be vulnerable to generics?</title>
 <link>http://www.fiercepharma.com/story/could-clarinex-be-vulnerable-to-generics/2008-04-30?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> Consider this scenario from &lt;a href=&quot;http://www.fiercebiotech.com/pages/schering-plough-ceo-fred-hassan&quot;&gt;Fred Hassan&#039;s&lt;/a&gt; nightmares: The $800 million Clarinex, ostensibly under patent till 2020, &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/could-clarinex-be-vulnerable-to-generics/2008-04-30&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/could-clarinex-be-vulnerable-to-generics/2008-04-30#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/clarinex">Clarinex</category>
 <category domain="http://www.fiercepharma.com/tags/congress">Congress</category>
 <category domain="http://www.fiercepharma.com/tags/fred-hassan">Fred Hassan</category>
 <category domain="http://www.fiercepharma.com/tags/generic-competition">generic competition</category>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/india">India</category>
 <category domain="http://www.fiercepharma.com/tags/orchid-chemicals">Orchid Chemicals</category>
 <category domain="http://www.fiercepharma.com/tags/profits">profits</category>
 <pubDate>Wed, 30 Apr 2008 06:59:55 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8926 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Zyrtec &#039;guerilla&#039; flyers spur blog buzz</title>
 <link>http://www.fiercepharma.com/story/zyrtec-guerilla-flyers-spur-blog-buzz/2008-04-22?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> A new guerilla marketing campaign for over-the-counter Zyrtec proves one thing: If you want attention in the blogosphere, post a few drug ads on telephone poles. They&#039;re flyers designed to appear &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/zyrtec-guerilla-flyers-spur-blog-buzz/2008-04-22&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/zyrtec-guerilla-flyers-spur-blog-buzz/2008-04-22#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/claritin">Claritin</category>
 <category domain="http://www.fiercepharma.com/tags/drug-advertising">Drug advertising</category>
 <category domain="http://www.fiercepharma.com/tags/dtc-advertising">DTC advertising</category>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/pfizer">Pfizer</category>
 <category domain="http://www.fiercepharma.com/tags/zyrtek">Zyrtek</category>
 <pubDate>Tue, 22 Apr 2008 06:59:55 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8884 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>FDA probe clears generic Wellbutrin</title>
 <link>http://www.fiercepharma.com/story/fda-probe-clears-generic-wellbutrin/2008-04-17?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> Listen to all those generics makers heaving sighs of relief. The FDA has given the thumbs-up to Teva&#039;s generic Wellbutrin XL, which has been under investigation since early last year. Patients who&#039;d &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/fda-probe-clears-generic-wellbutrin/2008-04-17&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/fda-probe-clears-generic-wellbutrin/2008-04-17#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/drug-safety">drug safety</category>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/glaxosmithkline">GlaxoSmithKline</category>
 <category domain="http://www.fiercepharma.com/tags/teva">Teva</category>
 <category domain="http://www.fiercepharma.com/tags/wellbutrin-xl">Wellbutrin XL</category>
 <pubDate>Thu, 17 Apr 2008 06:59:54 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8857 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>FiercePharma passes 20K subscribers</title>
 <link>http://www.fiercepharma.com/story/fiercepharma-passes-20k-subscribers/2008-04-08?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> Publisher&#039;s Note Last week the FiercePharma newsletter passed the 20,000 subscriber mark.  Thousands of more people are reading via the website and RSS feeds, and I want to thank everyone who has &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/fiercepharma-passes-20k-subscribers/2008-04-08&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/fiercepharma-passes-20k-subscribers/2008-04-08#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/fda">FDA</category>
 <category domain="http://www.fiercepharma.com/tags/fda-news">FDA news</category>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <pubDate>Tue, 08 Apr 2008 06:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8805 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Caraco to withdraw misshaped metformin</title>
 <link>http://www.fiercepharma.com/story/caraco-to-withdraw-misshaped-metformin/2008-03-25?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>A couple of weeks ago, the Los Angeles Times ran a big package about generic meds. &lt;A href=&quot;http://www.fiercepharma.com/story/op-ed-generics-arent-always-equal/2007-12-20&quot;&gt;Are they really as good as&lt;/a&gt; &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/caraco-to-withdraw-misshaped-metformin/2008-03-25&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/caraco-to-withdraw-misshaped-metformin/2008-03-25#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/diabetes">Diabetes</category>
 <category domain="http://www.fiercepharma.com/tags/fda">FDA</category>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/sun-pharmaceuticals">Sun Pharmaceuticals</category>
 <pubDate>Tue, 25 Mar 2008 07:59:54 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8737 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Pfizer might be liable for generic Neurontin</title>
 <link>http://www.fiercepharma.com/story/pfizer-might-be-liable-for-generic-neurontin/2008-03-24?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>You may pay the fine though you never collected the revenue. That&#039;s what a Philadelphia judge told Pfizer and Warner-Lambert last week in a trial over off-label marketing of Neurontin. If the &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/pfizer-might-be-liable-for-generic-neurontin/2008-03-24&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/pfizer-might-be-liable-for-generic-neurontin/2008-03-24#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/fda">FDA</category>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/patent">Patent</category>
 <category domain="http://www.fiercepharma.com/tags/pfizer">Pfizer</category>
 <pubDate>Mon, 24 Mar 2008 07:59:54 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8730 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>SPOTLIGHT:  Thais to make their own generics</title>
 <link>http://www.fiercepharma.com/story/spotlight-thais-to-make-their-own-generics/2008-03-13?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>After announcing that it would bust the patents on four cancer meds, Thailand now says it&#039;s building a plant to make local versions of several anti-AIDS meds and the heart drug Clopidogrel. The &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/spotlight-thais-to-make-their-own-generics/2008-03-13&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/spotlight-thais-to-make-their-own-generics/2008-03-13#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/patents">Patents</category>
 <pubDate>Thu, 13 Mar 2008 07:59:52 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8686 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Courts more open to patent-busting</title>
 <link>http://www.fiercepharma.com/story/courts-more-open-to-patent-busting/2008-03-11?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>Patents aren&#039;t just an issue in Thailand, either. These days, drugmakers are having a more difficult time keeping patent protection on their products, the Financial Times notes. Ever since top U.S. &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/courts-more-open-to-patent-busting/2008-03-11&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/courts-more-open-to-patent-busting/2008-03-11#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/bayer">Bayer</category>
 <category domain="http://www.fiercepharma.com/tags/bms">BMS</category>
 <category domain="http://www.fiercepharma.com/tags/contraceptive">Contraceptive</category>
 <category domain="http://www.fiercepharma.com/tags/genentech">Genentech</category>
 <category domain="http://www.fiercepharma.com/tags/generics">Generics</category>
 <category domain="http://www.fiercepharma.com/tags/lawsuits">lawsuits</category>
 <category domain="http://www.fiercepharma.com/tags/pfizer">Pfizer</category>
 <category domain="http://www.fiercepharma.com/tags/yasmin">Yasmin</category>
 <pubDate>Tue, 11 Mar 2008 07:59:56 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8676 at http://www.fiercepharma.com</guid>
</item>
</channel>
</rss>
